Price change (24h):
1.26%
High (24h):
$0.00022135
Low (24h):
$0.00021245
Volume (24h):
$797.25
Market Cap:
$213.45K
All Time High:
99.91% $0.25
Nov 18, 2024
All Time Low:
34% $0.00
Jun 6, 2026
90.93 %(1Y)
$0.00021352
Price change (24h):
1.26%
High (24h):
$0.00022135
Low (24h):
$0.00021245
Volume (24h):
$797.25
Market Cap:
$213.45K
All Time High:
99.91% $0.25
Nov 18, 2024
All Time Low:
34% $0.00
Jun 6, 2026
Rifampicin (RIF) is a cryptocurrency. It sits at the odd intersection of meme coin virality and the meticulous rigors of Decentralized Science (DeSci), catalogued under both the Solana and Pump.fun ecosystems.
The token’s entire utility orbits the Pump Science platform, a gamified longevity research arena where capital meets the petri dish. That specific friction it tears open is the closed, slow-moving gate of traditional biotech funding, replacing it with a live-streamed, tokenized prediction market for anti-aging compounds. Every trade becomes a micro-wager on cellular senescence.
Rifampicin operates on the Solana network. The chain’s sub-second finality and negligible fees absorb the frantic, high-frequency trading patterns typical of meme-adjacent assets without choking on gas costs.
Technically, the asset exists as an SPL token, natively inheriting Solana’s composability with decentralized exchanges and automated market makers. The smart contract, traceable at its mint address GJtJuWD9qYcC…, anchors a supply that requires no bridging or wrapping. No Ethereum Virtual Machine compatibility, no Byzantine Fault Tolerance to configure—just a lightweight SPL ledger entry that draws its security from Solana's proof-of-stake validator set.
The token bubbled up through Pump.fun’s permissionless launchpad. While no single founder’s name tags the token explicitly, its parent architecture—the Pump Science experiment suite—materialized from the Molecule ecosystem, which has spent years building infrastructure to tokenize intellectual property and early-stage pharmaceutical research. The whitepaper’s gitbook documents the mechanics, but the asset’s soul is the continuous, public data stream of Caenorhabditis elegans worms swimming in Rifampicin solutions.
The project’s long-term design is a lateral attack on the scientific funding bottleneck. Instead of relying on grant committees, the token grafts a speculative layer directly onto preclinical longevity trials, making the testing of senolytic compounds a matter of transparent, financially incentivized crowd observation. This is a market-based instrument for hypothesis validation, not a pharmaceutical endorsement.
Mechanically, the token acts as a pure representation of a single longevity experiment. Its price oscillates not on earnings reports but on the visual, real-time data of nematode motility, lifespan extension curves, and oxidative stress resistance. The token is the settlement layer for expectations about whether an old antibiotic can teach cells to withstand time.
Speculators buy the token to anchor a belief in Rifampicin’s pro-longevity effects, their position tracking the compound’s performance in an ongoing worm experiment. The Pump Science interface streams the biological data openly; a spike in median survival among the model organisms creates a reflexive pressure on the token’s order books. No governance votes, no staking yields—just a vertiginous correlation between a pipette and a candlestick chart.
Rifampicin has a maximum supply of 1,000,000,000 tokens. Currently, 999,655,351.80 are in circulation. With a market capitalization of $266,893.00, Rifampicin ranks #4,440 among all cryptocurrencies.
| Date | Open | Close | High | Low |
|---|---|---|---|---|
| 10/07/2026 | $0.00 | $0.00 | $0.00 | $0.00 |
| 09/07/2026 | $0.00 | $0.00 | $0.00 | $0.00 |
| 08/07/2026 | $0.00 | $0.00 | $0.00 | $0.00 |
| 07/07/2026 | $0.00 | $0.00 | $0.00 | $0.00 |
| 06/07/2026 | $0.00 | $0.00 | $0.00 | $0.00 |
| 05/07/2026 | $0.00 | $0.00 | $0.00 | $0.00 |
| 04/07/2026 | $0.00 | $0.00 | $0.00 | $0.00 |
| 03/07/2026 | $0.00 | $0.00 | $0.00 | $0.00 |
AI trades 24/7 automatically Catch every opportunity
Zero-emotion algorithm Disciplined strategy
Passive income Set & forget automation
20,000+
traders trusted Stoic AI
$200M+
in cumulative assets under management since inception
2015
year of company foundation
Disclaimer:
This website is operated by Cindicator Ltd. (“Cindicator”), a Gibraltar private company. You are solely responsible for compliance with all laws that may apply to you and your use of Cindicator products. Cryptocurrencies and blockchain technologies have been the subject of scrutiny by regulatory bodies worldwide. With respect to your use of Cindicator products, Cindicator makes no representations regarding the applicability or compliance of its products with any laws or regulations, including, without limitation, those related to trading, options, derivatives, or securities. You also assume all legal, economic, and other risks related to your use of Cindicator products, including legal uncertainty, market volatility, and information security risks, among others. Trading in cryptocurrencies and digital assets is highly speculative, and the value of investments can fluctuate dramatically. You may lose a substantial portion or even all of your invested capital, and such trading may not be suitable for everyone. If you are unsure about these risks or your ability to bear potential losses, you should consult with an independent financial advisor before using Cindicator products. Depending on your jurisdiction, access to or use of Cindicator products may be subject to certain legal restrictions or prohibitions. You agree that it is solely your responsibility to determine and comply with any laws and regulations applicable to your use of Cindicator products, and that Cindicator is not responsible for informing you of such requirements.
Cindicator reserves the right to restrict or refuse access to its products for citizens or residents of certain jurisdictions, including those subject to international sanctions or other legal restrictions. All materials provided on this website (including any graphical materials regarding trading strategy performance or P&L) are presented solely for marketing and informational purposes. They do not guarantee any future profits and should not be construed as financial, investment, legal, or other professional advice. Cindicator is not a registered broker-dealer, investment adviser, or regulated financial institution, and the information and services provided do not constitute personal investment advice or a recommendation or offer to buy or sell any securities, cryptocurrencies, or other financial instruments. The information provided herein is summary in nature, does not purport to be complete, and is provided “as is” without any warranty as to its accuracy or completeness. All content may be updated or changed at any time without notice. Past performance is not indicative of future results. To the maximum extent permitted by law, Cindicator (including its directors, officers, and affiliates) shall not be liable for any loss or damage (direct, indirect, special, consequential, or incidental) arising from your use of Cindicator products, this website, or any information contained herein. Please read our Terms of Use for further details. If you do not agree with these terms, please close this site.